» Articles » PMID: 11703617

Role of Contact System Activation in Hemodialyzer-induced Thrombogenicity

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2001 Nov 13
PMID 11703617
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The contact system is generally believed to be the main trigger of the coagulation cascade during extracorporeal circulation. However, the extent of contact activation, its role for intradialytic thrombin generation as well as the influence of different dialyzer membranes have not been well established.

Methods: In a novel full-scale ex vivo recirculation dialysis model, we investigated the thrombogenicity of three widely used hemodialyzers (Cuprophan Renak RA15-U, Polysulfone F6HPS and AN69XT Nephral 200). The activation of the contact system was evaluated using a newly developed ELISA for factor XIIa-C1-inhibitor complexes. Additionally, we determined free FXIIa (ELISA), thrombin-antithrombin (TAT) complexes, platelet factor 4 (PF4), complement activation (C5a), granulocyte elastase and blood cell counts. The findings in blood from normal volunteers were compared with factor XII-deficient blood.

Results: With normal blood AN69 exhibited the highest thrombogenicity in comparison to Cuprophan and Polysulfone, as assessed by TAT generation and platelet consumption. AN69 caused a rapid increase of the FXIIa-C1-inhibitor complexes and of free FXIIa. Despite significant TAT generation with Cuprophan and Polysulfone free FXIIa remained unchanged and the FXIIa-C1-inhibitor complexes stayed below the detection limit. With factor XII-deficient blood Polysulfone exhibited the same TAT generation, whereas the thrombogenicity of AN69 was greatly reduced.

Conclusions: Our data challenge the common assumption that activation of the contact system with generation of FXIIa is the main trigger for coagulation and thrombus formation in hemodialysis. Only the negatively charged AN69 membrane with enhanced thrombogenicity strongly induced contact activation.

Citing Articles

Antithrombotic coating with sheltered positive charges prevents contact activation by controlling factor XII-biointerface binding.

Ji H, Yu K, Abbina S, Xu L, Xu T, Cheng S Nat Mater. 2024; .

PMID: 39533064 DOI: 10.1038/s41563-024-02046-0.


Impact of renal replacement therapy modality on coagulation and platelet function in critically ill patients: A prospective observational study.

Im H, Jeong J, Oh S, Lim L, Lee H, Ryu H Artif Organs. 2024; 49(1):21-30.

PMID: 39301818 PMC: 11687214. DOI: 10.1111/aor.14872.


What is the role of the neutrophil extracellular traps in the cardiovascular disease burden associated with hemodialysis bioincompatibility?.

Cristol J, Thierry A, Bargnoux A, Morena-Carrere M, Canaud B Front Med (Lausanne). 2023; 10:1268748.

PMID: 38034546 PMC: 10684960. DOI: 10.3389/fmed.2023.1268748.


Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin.

Campo S, Lacquaniti A, Trombetta D, Smeriglio A, Monardo P J Clin Med. 2022; 11(13).

PMID: 35807042 PMC: 9267256. DOI: 10.3390/jcm11133759.


Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation.

Bowry S, Kircelli F, Himmele R, Nigwekar S Clin Kidney J. 2022; 14(Suppl 4):i59-i71.

PMID: 34987786 PMC: 8711760. DOI: 10.1093/ckj/sfab185.